Larimar Therapeutics Inc
(LRMR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,103 | 35,517 | 9,935 | 0 | N/A |
| Marketable Securities | 57,359 | N/A | N/A | 0 | N/A |
| Receivables | 391 | 1,617 | N/A | 0 | N/A |
| TOTAL | $117,198 | $37,358 | $10,324 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 79 | 37 | 32 | 0 | N/A |
| Other Non-Current Assets | 242 | 743 | 630 | 0 | 0 |
| TOTAL | $321 | $780 | $662 | $N/A | $N/A |
| Total Assets | $117,519 | $38,138 | $10,986 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,348 | 2,015 | 1,231 | 0 | 0 |
| Accrued Expenses | 3,172 | 900 | 1,699 | 0 | N/A |
| TOTAL | $6,901 | $2,915 | $2,930 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,177 | 0 | N/A | 0 | N/A |
| TOTAL | $6,177 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $13,078 | $2,915 | $2,930 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,237 | N/A | N/A | N/A | N/A |
| Common Shares | 23 | 1 | 1 | 0 | N/A |
| Retained earnings | -105,385 | -68,907 | -54,880 | 0 | N/A |
| Other shareholders' equity | -35 | 103,797 | 62,785 | 0 | 0 |
| TOTAL | $104,441 | $35,223 | $8,056 | $0 | $N/A |
| Total Liabilities And Equity | $117,519 | $38,138 | $10,986 | $0 | $0 |